Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University Hospital, Lille
With
Janssen Pharmaceuticals
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Psoriatic arthritis:
1. Men and women ≥ 18 years
2. Patients with PsA according to CASPAR criteria,
3. Patients who do not have yet started ustekinumab,
4. Patients who signed the informed consent.
Healthy volunteers:
1. Men and women ≥ 18 years
2. Patients who signed the informed consent.
You may not be if
Items 1 to 10 are applicable to healthy volunteers and PsA
1. History of fragility fracture AND / OR T-score ≤-3 if ≥50 years AND / OR Z-score ≤-3 if \<50 years during the screening phase,
2. Corticosteroids ≥10 mg / day,
3. Diseases or treatments affecting bone metabolism (breast cancer with anti-aromatase, malabsorption, primary hyperparathyroidism, uncontrolled hyperthyroidism ...),
4. History of radiotherapy on the lumbar spine or hip,
5. Patients undergoing hormone replacement therapy (HRT) or patients already on anti-osteoporotic therapy (bisphosphonates, strontium ranelate, teriparatide or denosumab),
6. Chronic kidney disease with creatinine clearance (CKD-EPI) ≤ 30 ml / min,
7. Weight\> 160 kg,
8. Patients under restrictive diet or considering a diet of this type during the study period,
9. Patients who have an intense exercise program or plan to benefit from it during the study period,
10. Pregnant or lactating women or having a pregnancy project,
